SAMDaily.us | SNOTE | 65 | Justification and Approval for Sole Source TPOXX Requirement

SAMDAILY.US - ISSUE OF FEBRUARY 24, 2024 SAM #8124
SPECIAL NOTICE

65 -- Justification and Approval for Sole Source TPOXX Requirement

Notice Date: 2/22/2024 1:22:49 PM
Notice Type: Justification
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: W6QK ACC-APG ABERDEEN PROVING GROU MD 21010-5424 USA
ZIP Code: 21010-5424
Solicitation Number: JA-24-Edg-173
Archive Date: 03/23/2024
Point of Contact: Scott Hoffman, Phone: +1 (520) 671-1470, Alexander Mayatte, Phone: +1 (520) 671-2930
E-Mail Address: scott.i.hoffman2.civ@army.mil, alexander.z.mayatte.civ@army.mil
(scott.i.hoffman2.civ@army.mil, alexander.z.mayatte.civ@army.mil)
Award Number: W911SR-22-C-0051
Award Date: 02/15/2024
Description: The purpose of this sole source within scope modification to Siga Technologies Inc., is to procure additional doses of TPOXX thereby replenishing existing National Stockpile quantities. TPOXX is an oral Smallpox Treatment in capsule form, approved by the United States Food and Drug Administration in 2018.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/02c302e2c4fd4b08b9d67fa8bc2e89e4/view)
Place of Performance: Address: New York, NY 10065, USA; Zip Code: 10065; Country: USA
Record: SN06973477-F 20240224/240222230043 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |